Driven by the adoption of rechargeable hearing aids and the conversion from functional devices, the global hearing aid battery market is set to transition into a decline. Specifically, the zinc-air hearing aid batteries are decreasing. Previously the zinc-air battery market was valued at nearly $1.3 billion and is expected to reach $1.2 billion by 2026.
The FDA has granted approval of the Cochlear products Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 Implant users, and the Custom Sound Pro fitting software. Kanso 2 According to Cochlear, the Kanso 2 is the world’s smallest off-the-ear sound processor for cochlear implants. It is also the first of its
Register to receive a free U.S. Hearing Aid Market Analysis report synopsis and brochure Users of cochlear implants, bone-conduction hearing devices or middle-ear hearing devices may experience adverse effects on their cerebrospinal fluid (CSF). According to the FDA, if planted too closely to the CSF shunt system, the valve settings may over or underdrain. This
Register to receive a free U.S. Market Report Suite for Hearing Devices – MedSuite report synopsis and brochure Oticon Medical announced the launch of Ponto 4, a breakthrough in bone anchored hearing care, on March 27th, 2019 at AudiologyNOW conference in Columbus, Ohio. This state-of-the-art sound processor is built on the one-of-a-kind Velox S™ platform, enabling Ponto
Register to receive a free US Hearing Devices Market Report Suite synopsis and brochure The U.S. Food and Drug Administration allowed marketing of a new device, the Bose Hearing Aid, intended to amplify sounds for individuals 18 years or older with perceived mild to moderate hearing impairment (hearing loss). This is the first hearing aid authorized for
Register to receive a free US Hearing Devices Market Report Suite synopsis and brochure Cochlear Limited, the global leader in implantable hearing solutions, announces the upcoming release of the Nucleus® Smart App for Android™ in the United States and Canada, offering greater connectivity than ever before for people with hearing loss and a cochlear implant. Cochlear implant
Register to receive a free US Hearing Devices Market Report Suite synopsis and brochure Audiology technology leader Signia announced the launch of its latest innovative hearing aids, Pure Charge&Go Nx. Combining wireless rechargeability through lithium-ion batteries and the most natural sound quality due to unique dual processing of the soundscape and wearer’s own voice—new Pure Charge&Go
Register to receive a free Hearing Devices Market Report Suite for US 2017-2023 synopsis and brochure Sensorion, a biotech company pioneering novel treatments for inner ear diseases, and Cochlear Limited, the global leader in implantable hearing solutions, today jointly announce a strategic collaboration focused on improving hearing outcomes in patients with cochlear implants. The collaboration will evaluate therapeutic
FDA approved the first telehealth option to program cochlear implants remotely
With this groundbreaking legislation Congress has sent a message to America that people with hearing loss need – and deserve – more affordable and accessible hearing health care.
